Why Biotech Must Change its Cleaning and Disinfection Strategy

01/07/2020 - 10 minutes

Many biotech companies deploy strong chemicals to clean and disinfect their equipment. However, if handled in the wrong way, this can lead to dangerous problems such as antibiotic resistance. As the EU prepares to release new guidelines on good manufacturing practices, it’s time to revise how cleaning is approached in the industry.

To effectively control contamination and ensure sterile work processes, the biotech industry is increasingly turning to harsh disinfectants. This trend roots in the common belief that aggressive disinfectants are the most efficient remedy, explained Angelika Hassler, quality manager at comprei, an Austrian company with over 20 years of experience in cleanroom maintenance. 

According to Hassler, this conception does not hold. “If the right strategy is in place and executed with proper materials by well-trained employees, it is not necessary to use aggressive agents.”

While aggressive cleansers and disinfectants do not necessarily give a better result than mild products, they can entail several adverse effects. For example, chlorine-based agents are not only aggressive against germs,

This content is available exclusively to our paying members.

Our members receive the following benefits:

  • Unlock premium articles
  • Download our industry reports
  • Remove all banner ads
  • Access 1,500+ archived posts
  • Support our independent media
Already a member? Sign in
ADVERTISEMENT Do you want to remove this advert? Become a member!
ADVERTISEMENT Do you want to remove this advert? Become a member!

You might also be interested in the following:


Support Us

Become a Member